Providence Cancer Institute (104) is a clinical research site located in Portland, Oregon, United States 97213.
Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.
Providence Cancer Institute (104) has participated in 1 clinical trials.
Therapeutic areas: Solid Tumor, Adult.
Sponsors: Immune-Onc Therapeutics.
Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Providence Cancer Institute (104) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Providence Cancer Institute (104) has 1 clinical trials on record. Their work covers Solid Tumor, Adult.
Providence Cancer Institute (104) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.